Close Menu

NEW YORK (GenomeWeb) – OraSure Technologies announced today that it has agreed to acquire early-stage microbiome services provider CoreBiome and urine sample collection device developer Novosanis.

The transactions are structured with an upfront payment and potential additional payments based on future performance. Additional financial terms were not disclosed. The deals are expected to close within the next week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.